Lupin to acquire two inhalation medicines from Sunovion Pharma for over Rs 623 crore Ruchika Sharma20 Oct 2022 12:15 PM ISTBrovana is indicated for long-term maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease, including...
Lupin gets 17 USFDA observations for Pune facility Ruchika Sharma20 Oct 2022 11:20 AM IST"The Company does not believe that the 483 letter will have an impact on the existing revenues from operations of this facility," Lupin stated.
Lupin, Global Agencies collaborate to support tuberculosis prevention treatment Ruchika Sharma7 Oct 2022 2:30 PM ISTMumbai: Global pharma major, Lupin Limited has announced that it has reached an agreement with Unitaid, The Aurum Institute, the Clinton Health Access...
Dr Shahin Fesharaki appointed as Lupin Global Chief Scientific Officer Ruchika Sharma7 Oct 2022 11:15 AM ISTDr Fesharaki most recently served as the Chief Scientific Officer and Global Head of R&D for Hikma Pharmaceuticals.
Lupin bags USFDA nod for HIV drug Darunavir Ruchika Sharma4 Oct 2022 3:16 PM ISTThe product will be manufactured at Lupin's facility in Nagpur, India.
Lupin gets USFDA EIR for Ankleshwar unit Ruchika Sharma3 Oct 2022 11:28 AM ISTThe inspection of the facility was conducted from August 16-19, 2022.
Lupin unveils generic equivalent of Revatio for Oral Suspension in US Ruchika Sharma30 Sept 2022 3:30 PM ISTThe medication is used to treat erectile dysfunction and pulmonary arterial hypertension.
Lupin bags USFDA approval for Mirabegron ER tablets to treat overactive bladder Ruchika Sharma30 Sept 2022 11:28 AM ISTThe product will be manufactured at Lupin's facility in Nagpur, India.
USFDA inspection: Lupin gets warning letter for Tarapur facility Ruchika Sharma29 Sept 2022 2:30 PM ISTMumbai: Pharma major, Lupin, has announced that the Company has received a warning letter from the US Food and Drug Administration (USFDA)...
Lupin bags USFDA nod for Diclofenac Sodium Topical Solution to treat arthritic knee pain Ruchika Sharma23 Sept 2022 11:15 AM ISTThe product will be manufactured at Lupin's facility in Pithampur, India.
Lupin gets Health Canada nod for plaque psoriasis treatment Rymti Ruchika Sharma13 Sept 2022 2:19 PM ISTMumbai: Global pharma major, Lupin Limited, announced today that Health Canada has approved Rymti, its biosimilar to Enbrel (etanercept), for use in...
Lupin unveils Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution in US Ruchika Sharma9 Sept 2022 12:27 PM ISTThe product is an osmotic laxative indicated for cleansing of the colon in preparation for colonoscopy in adults.
